Michael S. Cuffe Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months ago
Michael S. Cuffe has an estimated net worth of at least $28.3 million*, as of Oct. 29, 2025. They own 32,079 shares of HCA stock. They have sold 43,861 shares of HCA stock since 2021, for an estimated $13.5 million.
Michael S. Cuffe $HCA SEC Form 4 Insider Trading
Michael S. Cuffe has filed a total of 9 insider trades in $HCA since 2021. Their most recent trade was a sale of 1,500 shares, made on Feb 03, 2026. Their largest trade was a sale of 12,556 shares, made on Apr 28, 2023. We estimate that they now own 32,079 shares of $HCA, worth an estimated $14.8 million.
Insider Trading at $HCA
There have been a total of 143 insider trades reported at $HCA since 2021, with 95,131 shares purchased and 582,468 shares sold. The most active insider traders in $HCA stock have been Samuel N Hazen, Kathryn A. Torres, and Kathleen M Whalen. The most recent trade was a sale of 1,694 shares reported by Michael R McAlevey (EVP & Chief Legal & Admin Off.), made on Feb 18, 2026.
History of Insider Stock Trades by Michael S. Cuffe
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
HCA
|
Sale | 1,500 | Feb 03, 2026 | Feb. 5, 2026, 7:22 p.m. |
|
HCA
|
Sale | 3,836 | Sep 08, 2025 | Sept. 8, 2025, 6:37 p.m. |
|
HCA
|
Sale | 8,358 | Sep 12, 2024 | Sept. 12, 2024, 5:21 p.m. |
|
HCA
|
Sale | 6,311 | May 09, 2024 | May 13, 2024, 5:08 p.m. |
|
HCA
|
Sale | 1,600 | May 06, 2024 | May 8, 2024, 5:43 p.m. |
|
HCA
|
Sale | 3,200 | Jan 31, 2024 | Feb. 2, 2024, 7:38 p.m. |
|
HCA
|
Sale | 12,556 | Apr 28, 2023 | May 2, 2023, 5:30 p.m. |
|
HCA
|
Sale | 4,000 | Feb 01, 2023 | Feb. 1, 2023, 8:57 p.m. |
|
HCA
|
Sale | 2,500 | Aug 03, 2021 | Aug. 4, 2021, 8 p.m. |
$HCA Executives and Stock Owners with Insider Trades
-
Samuel N Hazen, CEO
-
Kathryn A. Torres, SVP-Payer Contracting & Align.
-
Kathleen M Whalen, SVP & Chief Ethics Officer
-
Michael S. Cuffe, EVP and Chief Clinical Officer
-
Jennifer Berres, SVP & Chief Human Res. Officer
-
Charles J Hall, Group President
-
Christopher F. Wyatt, SVP & Controller
-
P. Martin Paslick, SVP and CIO
-
Jane D. Englebright, SVP and Chief Nursing Officer
-
Jonathan B Perlin, Pres-Clinical Operations & CMO
-
Bill B Rutherford, CFO and EVP
-
Joseph A Iii Sowell, SVP; Chief Development Officer
-
Phillip G Billington, SVP-Internal Audit Services
-
A Bruce Jr Moore, Group President - Service Line
-
Jon M Foster, Group President
-
Erol R Akdamar, Group President
-
Deborah M Reiner, SVP - Mktg. & Communications
-
Chad J Wasserman, SVP and CIO
-
Jon M Foster, EVP and COO
-
Michael R Mcalevey, EVP & Chief Legal & Admin Off.
-
Jeffrey E. Cohen, SVP-Government Relations
-
Timothy M Mcmanus, Group President
-
Michael R Mcalevey, SVP & Chief Legal Officer
-
Michael S. Cuffe, President-Physician Services
-
Sammie S Mosier, SVP & Chief Nurse Executive
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.